Jaya Goyal

Jaya serves as the Executive Vice President of Research and Preclinical Development at PepGen. Jaya holds nearly 30 years of experience in biotech R&D including extensive experience in rare disease research. Previously, she served as Senior Vice President, Preclinical and Clinical Development Sciences at Wave Life Sciences where she led preclinical pharmacology, toxicology, bioanalytical, DMPK, clinical pharmacology and biomarker functions to support the preclinical and clinical development of nucleic acid-based therapeutics for fatal neurological diseases, including moving multiple candidates successfully from preclinical to clinical development. Previously, she worked at Biogen in roles of increasing responsibility, including Senior Director, Value Based Medicine, where she directed patient stratification and personalized medicine approaches for people with multiple sclerosis (MS). She trained as a postdoctoral fellow at New England Medical Center and Rush Presbyterian St. Luke’s Medical Center after completing her Ph.D. in Biochemistry at Central Drug Research Institute in India.